KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to 1180.05%.

  • Precigen's EBITDA Margin rose 10510100.0% to 1180.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 1860.15%, marking a year-over-year increase of 16911200.0%. This contributed to the annual value of 3440.23% for FY2024, which is 18376900.0% down from last year.
  • According to the latest figures from Q3 2025, Precigen's EBITDA Margin is 1180.05%, which was up 10510100.0% from 3710.75% recorded in Q2 2025.
  • Precigen's EBITDA Margin's 5-year high stood at 45.53% during Q3 2022, with a 5-year trough of 8485.5% in Q2 2024.
  • Its 5-year average for EBITDA Margin is 1750.65%, with a median of 1236.36% in 2022.
  • As far as peak fluctuations go, Precigen's EBITDA Margin tumbled by -72902500bps in 2024, and later soared by 47747500bps in 2025.
  • Quarter analysis of 5 years shows Precigen's EBITDA Margin stood at 593.7% in 2021, then tumbled by -108bps to 1236.36% in 2022, then plummeted by -125bps to 2786.97% in 2023, then rose by 14bps to 2396.3% in 2024, then soared by 51bps to 1180.05% in 2025.
  • Its EBITDA Margin stands at 1180.05% for Q3 2025, versus 3710.75% for Q2 2025 and 1685.01% for Q1 2025.